Blueprint Medicines stock is traded under the ticker #BPMC. Below you can review Blueprint Medicines stock performance in the past 12 months up to July 2026

Total visits to Blueprint Medicines's top domains

Understand Blueprint Medicines market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

blueprintmedicines.com21.5K

See more with Sales Intelligence

Avg. visit duration in Blueprint Medicines's top domains

Analyze Blueprint Medicines engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

blueprintmedicines.com00:01:10

See more with Sales Intelligence

Avg. pageviews on Blueprint Medicines's top domains

See how Blueprint Medicines keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

blueprintmedicines.com2.12

See more with Sales Intelligence

Blueprint Medicines top competitors by domain

Top similar sites in July 2026, ranked by their affinity

missionbio.comCompany NameMission BioEmployees51 - 200HQUnited States, California, South San FranciscoAnnual revenue$15M - $25MTotal visits16.3KScience and Education > Biology

Top technologies used by Blueprint Medicines

These are the website technologies, by industry, used by Blueprint Medicines top domains

Advertising (3)

DoubleClick

Mobile (3)

Meta Viewport

Content Management System (2)

WordPress

Conversion & Analytics (2)

Google Analytics

More Technologies

9

See all

News & Signals from Blueprint Medicines

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBlueprint Medicines Corporation closes offices in CB2 3HX, United Kingdom, Northern Europe, Europe.Blueprint's facilities at 45 Sidney St and 38 Sidney St in Cambridge are closing, with remaining Blueprint employees reporting to Sanofi's East Cambridge office.

NewsHo leaves Blueprint Medicines Corporation as chief business officer.Ho joins from Blueprint Medicines, where she served as chief business officer and led a series of transactions generating more than $1 billion.

NewsLee left Blueprint Medicines Corporation on Oct 17th '25.Lee joins AdvanCell from Blueprint Medicines Corporation, recently acquired by Sanofi for approximately $9.5 billion.